Corrigendum to "Methylated urolithin A, mitigates cognitive impairment by inhibiting NLRP3 inflammasome and ameliorating mitochondrial dysfunction in aging mice"
机构：[1]Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan, Hubei, 430060, PR China. Electronic address: 2282968908@qq.com.[2]Department of Pharmacy, Huangshi Central Hospital, Affiliated Hospital of Hubei Polytechnic University, Huangshi, Hubei, 435099, PR China.[3]Department of Pharmacy, Wuhan Third Hospital, Tongren Hospital of Wuhan University, Wuhan, Hubei, 430060, PR China.[4]Department of Endocrinology, Renmin Hospital of Wuhan University, Wuhan, Hubei, 430060, PR China; Hubei Key Laboratory of Wudang Local Chinese Medicine Research, School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan, Hubei, PR China.[5]Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan, Hubei, 430060, PR China.
第一作者机构：[1]Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan, Hubei, 430060, PR China. Electronic address: 2282968908@qq.com.
推荐引用方式(GB/T 7714)：
Chen Peng,Wang Yulai,Xie Jing,et al.Corrigendum to "Methylated urolithin A, mitigates cognitive impairment by inhibiting NLRP3 inflammasome and ameliorating mitochondrial dysfunction in aging mice"[J].Neuropharmacology.2024,109990.doi:10.1016/j.neuropharm.2024.109990.
APA：
Chen Peng,Wang Yulai,Xie Jing,Lei Jiexin&Zhou Benhong.(2024).Corrigendum to "Methylated urolithin A, mitigates cognitive impairment by inhibiting NLRP3 inflammasome and ameliorating mitochondrial dysfunction in aging mice".Neuropharmacology,,
MLA：
Chen Peng,et al."Corrigendum to "Methylated urolithin A, mitigates cognitive impairment by inhibiting NLRP3 inflammasome and ameliorating mitochondrial dysfunction in aging mice"".Neuropharmacology .(2024):109990
